Illumina, Inc. (ILMN) Given Consensus Recommendation of "Buy" by Analysts

Illumina, Inc. (ILMN) Given Consensus Recommendation of "Buy" by Analysts

Illumina, Inc. has been given a consensus rating of "Buy" by the twenty-five ratings firms that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and fourteen have given a buy recommendation to the company.

from Biotech News